Zobrazeno 1 - 10
of 735
pro vyhledávání: '"Fliegner, D."'
Autor:
Reis F; Medical Affairs, Pfizer Pharma GmbH, Friedrichstr. 110, 10117, Berlin, Germany., Rajaeean N; Medical Affairs, Pfizer Pharma GmbH, Friedrichstr. 110, 10117, Berlin, Germany., Divarci RR; Medical Affairs, Pfizer Pharma GmbH, Friedrichstr. 110, 10117, Berlin, Germany., Sollacher V; Medical Affairs, Pfizer Pharma GmbH, Friedrichstr. 110, 10117, Berlin, Germany. veit.sollacher@pfizer.com., Dworatzek E; Medical Affairs, Pfizer Pharma GmbH, Friedrichstr. 110, 10117, Berlin, Germany., Fliegner D; Medical Affairs, Pfizer Pharma GmbH, Friedrichstr. 110, 10117, Berlin, Germany., Krüger H; Medical Affairs, Pfizer Pharma GmbH, Friedrichstr. 110, 10117, Berlin, Germany., Lenz C; Medical Affairs, Pfizer Pharma GmbH, Friedrichstr. 110, 10117, Berlin, Germany., Craesmeyer C; Medical Affairs, Pfizer Pharma GmbH, Friedrichstr. 110, 10117, Berlin, Germany.
Publikováno v:
Pharmaceutical medicine [Pharmaceut Med] 2024 Sep; Vol. 38 (5), pp. 355-363. Date of Electronic Publication: 2024 Aug 01.
Autor:
Tentyukov, M., Fliegner, D., Frank, M., Onischenko, A., Retey, A., Staudenmaier, H. M., Vermaseren, J. A. M.
After an introduction to the sequential version of FORM and the mechanisms behind, we report on the status of our project of parallelization. We have now a parallel version of FORM running on Cluster- and SMP-architectures. This version can be used t
Externí odkaz:
http://arxiv.org/abs/cs/0407066
The present paper is the first of a series of papers reporting on the parallelization of the symbolic manipulation program FORM on different parallel architectures. Part I deals with workstation clusters using dedicated network hardware and the messa
Externí odkaz:
http://arxiv.org/abs/hep-ph/0007221
After an introduction to the sequential version of FORM and the mechanisms behind it we report on the status of our ongoing project of its parallelization. An analysis of the parallel platforms used is given and the structure of a parallel prototype
Externí odkaz:
http://arxiv.org/abs/hep-ph/9906426
Publikováno v:
Annals Phys. 264 (1998) 51-74
We apply the string inspired worldline formalism to the calculation of the higher derivative expansion of one-loop effective actions in non-Abelian gauge theory. For this purpose, we have completely computerized the method, using the symbolic manipul
Externí odkaz:
http://arxiv.org/abs/hep-th/9707189
Publikováno v:
Nucl.Instrum.Meth. A389 (1997) 374-377
Higher order coefficients of the inverse mass expansion of one-loop effective actions are obtained from a one-dimensional path integral representation. For the case of a massive scalar loop in the background of both a scalar potential and a (non Abel
Externí odkaz:
http://arxiv.org/abs/hep-th/9702092
Publikováno v:
Discourses Math.Appl.4:87-99,1995
The one--loop effective action for the case of a massive scalar loop in the background of both a scalar potential and an abelian or non--abelian gauge field is written in a one--dimensional path integral representation. From this the inverse mass exp
Externí odkaz:
http://arxiv.org/abs/hep-th/9411177
Publikováno v:
Z.Phys.C64:111-116,1994
The higher derivative expansion of the one-loop effective action for an external scalar potential is calculated to order O(T**7), using the string-inspired Bern-Kosower method in the first quantized path integral formulation. Comparisons are made wit
Externí odkaz:
http://arxiv.org/abs/hep-ph/9401221
Autor:
Fliegner D; Institute of Gender in Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.; Medical Affairs Internal Medicine, Pfizer Pharma GmbH, Berlin, Germany., Ellieva A; Institute of Gender in Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Angelov A; Institute of Gender in Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Petrov G; University of Witten- Herdecke, Witten, Germany., Regitz-Zagrosek V; Institute of Gender in Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.; Clinic for Cardiology, University Hospital Zürich, Zürich, Switzerland.
Publikováno v:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Oct 17; Vol. 14, pp. 1181044. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023).
Autor:
Meibom D; Bayer AG, 42113 Wuppertal, Germany., Micus S; Bayer AG, 42113 Wuppertal, Germany., Andreevski AL; Bayer AG, 42113 Wuppertal, Germany., Anlauf S; Bayer AG, 42113 Wuppertal, Germany., Bogner P; Bayer AG, 42113 Wuppertal, Germany., von Buehler CJ; Bayer AG, 42113 Wuppertal, Germany., Dieskau AP; Bayer AG, 42113 Wuppertal, Germany., Dreher J; Bayer AG, 42113 Wuppertal, Germany., Eitner F; Bayer AG, 42113 Wuppertal, Germany., Fliegner D; Bayer AG, 42113 Wuppertal, Germany., Follmann M; Bayer AG, 42113 Wuppertal, Germany., Gericke KM; Bayer AG, 42113 Wuppertal, Germany., Maassen S; Bayer AG, 42113 Wuppertal, Germany., Meyer J; Bayer AG, 42113 Wuppertal, Germany., Schlemmer KH; Bayer AG, 42113 Wuppertal, Germany., Steuber H; Bayer AG, 13353 Berlin, Germany., Tersteegen A; Bayer AG, 42113 Wuppertal, Germany., Wunder F; Bayer AG, 42113 Wuppertal, Germany.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2022 Dec 22; Vol. 65 (24), pp. 16420-16431. Date of Electronic Publication: 2022 Dec 07.